An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone online asked if taking two experimental peptides helped heal an Achilles tendon injury. They tried a low daily dose of one peptide (BPC‑157) and a once‑weekly dose of another (TB‑500) for five weeks and felt no improvement. Then they increased the BPC‑157 dose and doubled the TB‑500 frequency and asked whether that should be enough, or if daily TB‑500 is better. BPC‑157 and TB‑500 are short chains of amino acids called peptides. They’re not the same as common drugs like Ozempic, but people talk about them for tissue healing. BPC‑157 comes from a naturally occurring stomach protein and is claimed to help tendons and gut tissue. TB‑500 is a fragment of a protein called thymosin beta‑4 and is promoted for reducing inflammation and encouraging cells to move into injured areas. Important: neither peptide is an approved, well‑studied medicine for tendon repair in humans. What the research actually shows is limited and mostly not in people. Most studies are from lab experiments or animals, where researchers sometimes see faster healing, less scarring, or better cell movement with these peptides. Rigorous clinical trials in humans are scarce or small, and anecdotes online vary a lot. From that snippet alone you can’t conclude whether the doses used were adequate, because there’s no standard, FDA‑approved dosing, and the evidence base doesn’t firmly link a specific daily dose to predictable benefit in humans. Why this matters: Achilles tendon injuries can be slow and frustrating to heal. People who want faster recovery sometimes look to novel options when physical therapy, rest, and established treatments don’t give quick results. That’s why threads about BPC‑157 and TB‑500 get attention: they promise tissue repair. But because the science is uncertain, someone recovering from an injury should weigh unproven treatments against proven approaches like guided rehab, load management, and seeing a sports medicine or orthopedic specialist. Caveats and risks are important. These peptides are often sold as research chemicals, not regulated medicines, so purity and dosing can be inconsistent. Side effects aren’t well documented in humans. Using higher or daily doses without medical supervision can be risky. Also, because they haven’t passed large clinical trials, doctors can’t guarantee safety, effectiveness, or interactions with other conditions or medications. If you’re thinking of trying them, discuss it with a qualified clinician, consider safer validated therapies first, and be cautious about sourcing and dosing. Bottom line: some lab and animal studies hint these peptides might help tendon healing, but human evidence is weak, dosing is unstandardized, and safety is uncertain — so proceed carefully and consult a medical professional.
Source: r/Peptides